Bryan E. Smith
General Counsel, Corporate Sec at Eledon Pharmaceuticals, Inc. (ELDN) since April 2021
Bryan E. Smith has filed 9 insider reports with the SEC since March 2021, as general Counsel and corporate Sec at Eledon Pharmaceuticals, Inc. (ELDN) and officer at Urovant Sciences Ltd. (UROV). The latest filing, on January 13, 2025, reports grant or award at Eledon Pharmaceuticals, Inc. (ELDN).
- Filings
- 9
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Bryan E. Smith is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals, Inc. | General Counsel, Corporate Secsince April 2021 | $2.87 | Jan 13, 2025 | ||||
| UROV Urovant Sciences Ltd. | Officer | 0 | Mar 31, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jan 10, 2025ELDNSEC Form 4 filed by General Counsel, Corporate Sec Smith Bryan E.Form 4Grant or award
- Nov 21, 2024ELDNSEC Form 4 filed by General Counsel, Corporate Sec Smith Bryan E.Form 4Grant or award
- Jun 13, 2024ELDNSEC Form 4 filed by General Counsel, Corporate Sec Smith Bryan E.Form 4Grant or award
- May 1, 2023ELDNSEC Form 4 filed by Smith Bryan E.Form 4Grant or award
- Feb 1, 2023ELDNSEC Form 4 filed by Smith Bryan E.Form 4Grant or award
- Feb 1, 2022ELDNSEC Form 4 filed by Smith Bryan E.Form 4Grant or award
- May 3, 2021ELDNSEC Form 4 filed by Smith Bryan E.Form 4Grant or award
- Apr 19, 2021ELDNSEC Form 3 filed by Smith Bryan E.Form 3New insider
- Mar 29, 2021UROVSEC Form 4: E. Bryan Smith disposed to the issuer $0 worth of Common Shares (124,447 units at $0.00), decreasing direct ownership by 100% to 0 unitsForm 4Sale back to the company
Also sits on boards with
Officers and directors who share two or more companies with Bryan E. Smith.
Compare Bryan E. Smith with
- Bryan E. Smith vs James A. Robinson Jr.2 shared
- Bryan E. Smith vs David-Alexandre C Gros1 shared
- Bryan E. Smith vs Steven Perrin1 shared
- Bryan E. Smith vs June Lee1 shared
- Bryan E. Smith vs Keith Katkin1 shared
- Bryan E. Smith vs John S. McBride1 shared
Other insiders at the same companies
- David-Alexandre C GrosELDN
- Steven PerrinELDN
- Keith KatkinELDN
- John S. McBrideELDN
- Jan HillsonELDN
- June LeeELDN
- Allan KirkELDN
- Paul Sean LittleELDN
Questions about Bryan E. Smith
- What is Bryan E. Smith's role at Eledon Pharmaceuticals, Inc.?
- Bryan E. Smith reports to the SEC as general Counsel and corporate Sec at Eledon Pharmaceuticals, Inc. (ELDN), according to the latest filing on January 13, 2025. Bryan E. Smith has also filed as officer at Urovant Sciences Ltd. (UROV).
- Has Bryan E. Smith bought or sold stock recently?
- No open-market purchases or sales by Bryan E. Smith are on file. The filings report grant or award and sale back to the company.
- How do I get alerts when Bryan E. Smith files?
- Follow Bryan E. Smith on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Bryan E. Smith (SEC CIK 0001748041). Totals count each trade once, skipping amendments whose original is on file, from Mar 31, 2021 on. View on SEC EDGAR